Results 1 to 10 of about 8,958 (210)

Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation. [PDF]

Viruses
Inoue H.
europepmc   +1 more source

Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors. [PDF]

J Neurooncol
Elgehiny A, Fan AE, Frost M, He J, Gary SE, Osorio DS, Zaky W, Zhou L, Kang KD, Zhang Z, Fueyo J, Gomez-Manzano C, Thompson EM, Bernstock JD, Friedman GK.   +14 more
europepmc   +1 more source

The Role of Viral Dynamics and Infectivity in Models of Oncolytic Virotherapy for Tumours with Different Motility. [PDF]

Bull Math Biol
Morselli D, Frascoli F, Delitala ME.
europepmc   +1 more source

The Emerging Role of Oncolytic Virotherapy in Glioblastoma Management. [PDF]

Cancers (Basel)
Nizamutdinov D, Sentmanat A, Tong J, Qi X, Pan Y, Qi D, Wu E, Huang JH.   +7 more
europepmc   +1 more source

Harnessing oncogenic signaling to enhance oncolytic virotherapy: Lessons from EPAC-encoding vaccinia virus. [PDF]

Mol Ther Oncol
Boulton S, Singh S, Bell JC.
europepmc   +1 more source

PD-L1 Immuno-PET Reveals Systemic Effects of Localized Oncolytic Virotherapy in a Mouse Model of Head and Neck Cancer. [PDF]

J Nucl Med
Höbart J, Da Pieve C, Raes F, Borys D, Mączyńska J, Sharma G, Melcher AA, Harrington KJ, Kramer-Marek G.   +8 more
europepmc   +1 more source

Engineering systemic oncolytic virotherapy through immune-compatible delivery and programmable tumor cell death. [PDF]

Mol Ther Oncol
Chen X, Chen Y, Ping Y.
europepmc   +1 more source

Targeting collagen to enhance oncolytic virotherapy outcome in gastric cancer patients. [PDF]

Mol Ther Oncol
Soni H.
europepmc   +1 more source

Oncolytic virotherapy and tumor microenvironment modulation. [PDF]

Clin Exp Med
Rivera-Orellana S, Bautista J, Palacios-Zavala D, Ojeda-Mosquera S, Altamirano-Colina A, Alcocer-Veintimilla M, Parrales-Rosales G, Izquierdo-Condoy JS, Vásconez-González J, Ortiz-Prado E, Muslin C, López-Cortés A.   +11 more
europepmc   +1 more source

Retraction: Oncolytic virotherapy promotes radiosensitivity in soft tissue sarcoma by suppressing anti-apoptotic MCL1 expression. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source